Alyeska Investment Group
ODT

Alyeska Investment Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Alyeska Investment Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,009
Closed -$734K – 541
2019
Q2 		$734K Buy
+20,009
New +$479K 0.01% 385

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Alyeska Investment Group's ODT Position: Q3 2019 in Review

Alyeska Investment Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2019, closing a stake of 20,009 shares — an estimated $734K sold.

Alyeska Investment Group first reported a position in ODT in Q2 2019 and held it in 1 quarter. The position peaked at $734K in Q2 2019. 82 funds tracked by Wall St. Rank hold ODT as of Q3 2019.

  • Alyeska Investment Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 20,009 Odonate Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $734K.
  • Alyeska Investment Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Alyeska Investment Group's Odonate Therapeutics, Inc. Common Stock position peaked at $734K in Q2 2019.
  • 82 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.